The SARS-CoV-2 (COVID-19) pandemic and diagnosis and treatment of women with abnormal uterine bleeding: findings from Brazil.

Publication date: Dec 11, 2024

To determine practice patterns in the diagnosis and management of nongestational abnormal uterine bleeding (AUB) in women in reproductive years during the SARS-CoV-2 (COVID-19) pandemic in Brazil. A web-based survey was conducted to determine the impact of the COVID-19 pandemic on the diagnosis and management of women with AUB. Survey elements included treatment location, the use of ultrasonography, laboratory evaluation for iron deficiency and some hormone determinations, and endometrial evaluation by histopathology, as well as the practice of hysteroscopy, hysterectomy and medical therapy including the placement of the 52 mg levonorgestrel-intrauterine system (LNG-IUS). The survey was completed electronically at scientific meetings or sent by e-mail to Brazil-based OBGYNs between April and September 2021 during the COVID-19 quarantine. Fully completed questionnaires were received from 541 physicians aged (mean +/- SD) 46. 6 +/- 12. 5 years. Whereas the overall number of AUB-related visits decreased (p 

Concepts Keywords
52mg abnormal uterine bleeding
Brazil COVID-19 pandemic
Endometrial heavy menstrual bleeding
Scientific LNG-IUS
Women telehealth

Semantics

Type Source Name
disease MESH COVID-19
disease MESH uterine bleeding
disease MESH iron deficiency
drug DRUGBANK Levonorgestrel
disease MESH heavy menstrual bleeding

Original Article

(Visited 2 times, 1 visits today)